AI Meets Personalization: A Healthcare Revolution on the Horizon
Expert insight from Maryam Ahmadi, Director of Science at Sphere Bio, explores how AI and personalized medicine are transforming drug discovery and patient outcomes.
PUBLISHED IN
ARTICLE TITLE
AUTHORS
FEATURED EXPERT
PUBLICATION DATE
The Medicine Maker
AI Meets Personalization — an excerpt from Chapter 9: Personalized, Precise Treatments
Stephanie Vine and Rob Coker
Maryam Ahmadi, Director of Science, Sphere Bio
July 24, 2025
The Future Is Personal—and Powered by AI
In Chapter 9: Personalized, Precise Treatments of The Medicine Maker’s Future of Pharma series, more than 100 industry experts weighed in on what’s next for the pharmaceutical industry. One clear theme emerged: the convergence of AI and personalized medicine is already disrupting the traditional model of drug discovery and delivery.
In this special feature, Maryam Ahmadi, Director of Science at Sphere Bio, shares her perspective on how this convergence is already reshaping timelines, costs, and—most importantly—patient outcomes.
“AI has revolutionized how we identify, optimize, and develop new drugs. But its greatest potential lies in personalized medicine.”
— Maryam Ahmadi, Director of Science, Sphere Bio
Key Takeaways:
Faster Drug Discovery
AI dramatically reduces development timelines by analyzing large datasets to identify drug targets, predict efficacy, and refine chemical structures. Ahmadi cites a striking example: an AI-developed drug by Insilico Medicine reached Phase I trials in just 30 months.
Smarter Clinical Trials
With AI improving patient recruitment, real-time monitoring, and predictive outcomes, trials are becoming faster, cheaper, and more accurate.
The Real Power: Precision Medicine
AI excels at making sense of complex genomic and health data, helping personalize treatment plans for individual patients—especially those with cancer or rare diseases.
Why Collaboration Matters
Ahmadi emphasizes that industry-wide collaboration—between academia, biotech, and pharma—is essential to safely and ethically harness AI’s full potential.
“As a relative of a cancer patient, I deeply appreciate the life-changing potential of AI and personalized medicine. Together, they represent a new era in healthcare.”
— Maryam Ahmadi
Read the Full Article
Discover how thought leaders like Maryam Ahmadi are helping to shape the next decade of pharma innovation in The Medicine Maker’s Future of Pharma feature.
This post is part of our Editorial Coverage series—highlighting how Sphere Bio experts are contributing to global conversations on innovation, biotherapeutics, and the future of drug development.
Stay informed as we continue to explore the technologies shaping tomorrow’s treatments.
Stay ahead with Sphere Bio
Join our community of forward-thinking scientists. Stay informed with the latest breakthroughs, product launches, and industry research. Subscribe to our newsletter and be the first to know about innovations that can transform your lab.
